Logo-jrip
J Renal Inj Prev. 2017;6(4): 297-302. doi: 10.15171/jrip.2017.57

Review

An update on allopurinol and kidney failure; new trend for an old drug

Amirhesam Alirezaei 1, Hassan Argani 1 * , Masoumeh Asgharpour 2, Ayad Bahadorimonfared 3, Mahmood Bakhtiyari 4,5

Cited by CrossRef: 7


1- Ungur D, Santiso-Quinones G, Pop M, Tamas T, Guguta C, Stam D, Mija A, Iordache C. Febuxostat–p-Toluenesulfonic Acid Multi-Component Crystal: Characterization, Crystal Growth and Elucidation of the Salt/Co-Crystal Nature. Crystals. 2023;13(5):836 [Crossref]
2- Ungur D, Lanza A, Stam D, Guguta C, Iordache C, Fruth V, Santiso-Quinones G, Pop M. Crystal structure of febuxostat marketed polymorph determined by electron diffraction and reinforced by X-ray crystallography. CrystEngComm. 2024;26(32):4295 [Crossref]
3- Asgharpour M, Alirezaei A. Herbal antioxidants in dialysis patients: a review of potential mechanisms and medical implications. Renal Failure. 2021;43(1):351 [Crossref]
4- Alvionita M, Oktavia I, Oktavia S, Oktavia M. Bioactivity of Flavonoid in Ethanol Extract of Annona squamosa L. Fruit as Xanthine Oxidase Inhibitor. IOP Conf Ser: Mater Sci Eng. 2019;546(6):062003 [Crossref]
5- Abdullah S, Rostamzadeh N, Sedig K, Lizotte D, Garg A, McArthur E. Machine Learning for Identifying Medication-Associated Acute Kidney Injury. Informatics. 2020;7(2):18 [Crossref]